First Tracks Biotherapeutics Announces Participation in September Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
First Tracks Biotherapeutics (Nasdaq: TRAX) will participate in three investor conferences in September 2026: the Wells Fargo Healthcare Conference on September 9 (fireside chat and 1x1s), Citi's Biopharma Back to School Conference on September 10 (1x1s), and the Morgan Stanley Global Healthcare Conference on September 16 (1x1s). A live webcast and 30-day replay of the Wells Fargo fireside chat will be available on the company's investor website.
Details
News Market Reaction – TRAX
On Aug 27, the first trading day after this news, TRAX closed 1.24% above the previous close.
Data tracked by StockTitan Argus for the Aug 27 session.
Key Figures
- Wells Fargo conference edition
- 21st Annual
- Healthcare Conference
- Fireside chat date
- Sept. 9, 2026
- Wells Fargo Healthcare Conference
- Fireside chat time
- 9:30am ET / 6:30am PT
- Wells Fargo Healthcare Conference
- Citi conference date
- Sept. 10, 2026
- Citi's 2026 Biopharma Back to School Conference
- Morgan Stanley conference edition
- 24th Annual
- Global Healthcare Conference
- Morgan Stanley conference date
- Sept. 16, 2026
- Morgan Stanley Global Healthcare Conference
- Webcast replay availability
- at least 30 days
- Following the event
Historical Context
-
Reported quarterly results, pipeline progress, and reiterated cash runway into Q2 2028
-
Announced participation in Jefferies and Leerink Partners investor events
-
Reported quarterly net loss and ongoing clinical development programs
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences:
21st Annual Wells Fargo Healthcare Conference, Boston
- Format – Fireside chat and one-on-one investor meetings
- Date and Time – Wednesday, Sept. 9, 2026 at 9:30am ET / 6:30am PT
Citi's 2026 Biopharma Back to School Conference, New York City
- Format – One-on-one investor meetings
- Date and Time – Thursday, Sept. 10, 2026
Morgan Stanley 24th Annual Global Healthcare Conference, New York City
- Format – One-on-one investor meetings
- Date and Time – Wednesday, Sept. 16, 2026
A live webcast of the fireside chat will be available on the investor section of the First Tracks website at https://ir.firsttracksbio.com/news-events/events. A replay of the webcast will be available for at least 30 days following the event.
About First Tracks Biotherapeutics
First Tracks Biotherapeutics is a clinical stage biotechnology company advancing antibody therapies that modulate immune pathways implicated in autoimmune and inflammatory diseases. Its pipeline includes ANB033, a CD122 antagonist in development for celiac disease and eosinophilic esophagitis; rosnilimab, a pathogenic T cell depleter in development for rheumatoid arthritis; and ANB101, a BDCA2 modulator. To learn more, visit www.FirstTracksBio.com or follow us on LinkedIn.
Investor Contact:
Nick Montemarano
Vice President, Investor Relations
858.732.0178
investors@firsttracksbio.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.